VEGFC and cervical cancer: In this prospective clinicopathological study, we found that standard markers of neoangiogenesis (CD31) and lymphangiogenesis (VEGF-C and D2-40) did not correlate with an increased risk of PLNM (including MICs and ITCs) or early recurrence in a cohort of early-stage cervical cancer patients.